These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30557306)

  • 1. Association and biomarker potential of elevated serum adiponectin with nephropathy among type 1 and type 2 diabetics: A meta-analysis.
    Pabalan N; Tiongco RE; Pandac JK; Paragas NA; Lasta SL; Gallego N; Jarjanazi H; Pineda-Cortel MR
    PLoS One; 2018; 13(12):e0208905. PubMed ID: 30557306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cystatin C as an early marker of nephropathy among type 2 diabetics: A meta-analysis.
    Arceo ES; Dizon GA; Tiongco REG
    Diabetes Metab Syndr; 2019; 13(6):3093-3097. PubMed ID: 31778883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total bilirubin level may be a biomarker of nephropathy in type 2 diabetes mellitus: A meta-analysis of observational studies based on MOOSE compliant.
    Zhang D; Zhu B; Zhang W; Wang W; Guo D; Yang L; Wang L
    Medicine (Baltimore); 2017 Jan; 96(1):e5765. PubMed ID: 28072721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH;
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An association between adiponectin and renal dysfunction in patients with type 2 diabetes mellitus].
    Galovičová A; Lazúrová I; Petrášová D
    Vnitr Lek; 2012 Nov; 58(11):825-9. PubMed ID: 23256827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential use of urinary transferrin, urinary adiponectin, urinary Retinol Binding Protein, and serum zinc alpha 2 glycoprotein levels as novel biomarkers for early diagnosis of diabetic nephropathy: A case-control study.
    Kamel MF; Nassar M; Elbendary A; Mohamed AGA; Abdullah MG; Gomaa HRA; Awad EMI; Mahmoud HH; Elfiki MA; Abdalla NH; Abd Elkareem RM; Soliman AS; Elmessiery RM
    Diabetes Metab Syndr; 2022 Apr; 16(4):102473. PubMed ID: 35405355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes.
    Nicolas A; Mohammedi K; Bastard JP; Fellahi S; Bellili-Muñoz N; Roussel R; Hadjadj S; Marre M; Velho G; Fumeron F
    Nephrol Dial Transplant; 2017 Dec; 32(12):1987-1993. PubMed ID: 28499019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy.
    Xu T; Xu X; Zhang L; Zhang K; Wei Q; Zhu L; Yu Y; Xiao L; Lin L; Qian W; Wang J; Ke M; An X; Liu S
    Front Endocrinol (Lausanne); 2021; 12():781417. PubMed ID: 34956093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
    El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
    IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
    Panduru NM; Saraheimo M; Forsblom C; Thorn LM; Gordin D; Wadén J; Tolonen N; Bierhaus A; Humpert PM; Groop PH;
    Diabetes Care; 2015 May; 38(5):883-90. PubMed ID: 25720601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Vitamin D-Binding Protein and Early Prediction of Nephropathy in Type 2 Saudi Diabetic Patients.
    Fawzy MS; Abu AlSel BT
    J Diabetes Res; 2018; 2018():8517929. PubMed ID: 29850609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
    El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
    Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J; Persson F; Hansen TW; Jorsal A; Tarnow L; Parving HH; Rossing P
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannose-Binding Lectin and Diabetic Nephropathy in Type 1 Diabetes.
    Zhao SQ; Hu Z
    J Clin Lab Anal; 2016 Jul; 30(4):345-50. PubMed ID: 26212019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of high-molecular-weight adiponectin in type 1 diabetes.
    Leth H; Andersen KK; Frystyk J; Tarnow L; Rossing P; Parving HH; Flyvbjerg A
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3186-91. PubMed ID: 18505763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin, total antioxidant status, and urine albumin excretion in the low-risk "Golden Years" type 1 diabetes mellitus cohort.
    Prior SL; Tang TS; Gill GV; Bain SC; Stephens JW
    Metabolism; 2011 Feb; 60(2):173-9. PubMed ID: 20188385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Adiponectin Level in Different Stages of Type 2 Diabetic Kidney Disease: A Meta-Analysis.
    Li L; Shi J; Wu G
    Comput Math Methods Med; 2022; 2022():1863243. PubMed ID: 35872926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy.
    Al-Kafaji G; Al-Muhtaresh HA
    Mol Med Rep; 2018 Jul; 18(1):1171-1180. PubMed ID: 29845236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.